Andrew Marr reveals he suffered a ‘nasty’ bout of Covid LAST WEEK despite having BOTH jabs
BBC news presenter Andrew Marr today revealed he contracted Covid-19 last week despite having been fully jabbed.
The 61-year-old journalist made the stunning admission this morning on his eponymous television programme.
He sad that he had symptoms akin to ‘a summer cold’ and said it had been ‘really, really quite unpleasant’.
He filmed his Sunday morning programme live from Cornwall on June 13 while the G7 was going on.
But he was not inside the closed off area at Carbis Bay, instead filming from the Tate St Ives gallery.
At the start of an interview today with Professor Sir Peter Horby, the chairman of virus advisory group Nervtag, he said: ‘I hope it is not self indulgent Sir Peter to ask you about me, because I got coronavirus last week.
The host made the admission this morning on his eponymous television programme and suggested he may have contracted it while covering the G7 summit in Cornwall earlier this month.
At the start of an interview with Professor Sir Peter Horby, the chairman of virus advisory group Nervtag, he said: ‘I hope it is not self indulgent Sir Peter to ask you about me, because I got coronavirus last week’
He filmed his Sunday morning programme live from the Tate St Ives in Cornwall on June 13, a fortnight ago.
‘I’d been double jabbed earlier in the spring and felt, if not king of the world, at least almost entirely immune. And yet I got it, was I just unlucky?’
Sir Peter replied: ‘I think you were. What we know with the vaccines is that they are actually remarkably effective at preventing hospitalisations and deaths.
They are less effective at preventing infection. So although you were sick you were not hospitalised and there wasn’t’ any fatality and that is probably because of the vaccination.’
Mr Marr, then 53, nearly died following a stroke in 2013 and was admitted to Charing Cross Hospital in the middle of the night.
So he is likely to have been vaccinated among the first wave as someone who is clinically vulnerable.